Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3145
Source ID: NCT00600626
Associated Drug: Biphasic Insulin Aspart
Title: Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: biphasic insulin aspart|DRUG: insulin NPH|DRUG: insulin aspart
Outcome Measures: Primary: HbA1c, after 4 months of treatment | Secondary: 8-point blood glucose profile|incidence of hypoglycaemic episodes|safety profiles|changes in body weight and vital signs
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 394
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2004-01
Completion Date: 2004-07
Results First Posted:
Last Update Posted: 2017-01-06
Locations: Novo Nordisk Investigational Site, Zagreb, 10 000, Croatia|Novo Nordisk Investigational Site, Lille, 59037, France|Novo Nordisk Investigational Site, NEVERS cedex, 58033, France|Novo Nordisk Investigational Site, Rennes, 35056, France|Novo Nordisk Investigational Site, Venissieux, 69200, France|Novo Nordisk Investigational Site, Bad Heilbrunn, 83670, Germany|Novo Nordisk Investigational Site, Neuss, 41460, Germany|Novo Nordisk Investigational Site, Schaafheim, 64850, Germany|Novo Nordisk Investigational Site, Schwedt, 16303, Germany|Novo Nordisk Investigational Site, St. Ingbert, 66386, Germany|Novo Nordisk Investigational Site, Völklingen, 66333, Germany|Novo Nordisk Investigational Site, Wiesbaden, 65183, Germany|Novo Nordisk Investigational Site, Würzburg, 97072, Germany|Novo Nordisk Investigational Site, Shatin, New Territories, Hong Kong|Novo Nordisk Investigational Site, Cheras, 56000, Malaysia|Novo Nordisk Investigational Site, Kota Bharu, Kelantan, 16150, Malaysia|Novo Nordisk Investigational Site, Beverwijk, 1942 LE, Netherlands|Novo Nordisk Investigational Site, Delft, 2625 AD, Netherlands|Novo Nordisk Investigational Site, Eindhoven, 5631 BM, Netherlands|Novo Nordisk Investigational Site, Rotterdam, 3011 TD, Netherlands|Novo Nordisk Investigational Site, Lodz, 90-030, Poland|Novo Nordisk Investigational Site, Lublin, 20-718, Poland|Novo Nordisk Investigational Site, Szczecin, 71-455, Poland|Novo Nordisk Investigational Site, Warszawa, 03-242, Poland|Novo Nordisk Investigational Site, Zabrze, 41-800, Poland|Novo Nordisk Investigational Site, Cluj Napoca, Cluj, 400006, Romania|Novo Nordisk Investigational Site, Constanta, 900591, Romania|Novo Nordisk Investigational Site, Iasi, 700111, Romania|Novo Nordisk Investigational Site, Timisoara, 300736, Romania|Novo Nordisk Investigational Site, Moscow, 117036, Russian Federation|Novo Nordisk Investigational Site, Moscow, 119435, Russian Federation|Novo Nordisk Investigational Site, Saint-Petersburg, 194291, Russian Federation|Novo Nordisk Investigational Site, Saint-Petersburg, 194354, Russian Federation|Novo Nordisk Investigational Site, Singapore, 119074, Singapore|Novo Nordisk Investigational Site, Córdoba, 14004, Spain|Novo Nordisk Investigational Site, Madrid, 28040, Spain|Novo Nordisk Investigational Site, Orihuela, 03300, Spain|Novo Nordisk Investigational Site, Sabadell, 08208, Spain|Novo Nordisk Investigational Site, Sevilla, 41009, Spain|Novo Nordisk Investigational Site, Sevilla, 41013, Spain|Novo Nordisk Investigational Site, Valladolid, 47011, Spain|Novo Nordisk Investigational Site, Falun, 791 82, Sweden|Novo Nordisk Investigational Site, Göteborg, 416 85, Sweden|Novo Nordisk Investigational Site, Linköping, 581 85, Sweden|Novo Nordisk Investigational Site, Lund, 221 85, Sweden|Novo Nordisk Investigational Site, Mölndal, 431 80, Sweden|Novo Nordisk Investigational Site, Uppsala, 751 85, Sweden|Novo Nordisk Investigational Site, Bradford, BD9 6RJ, United Kingdom|Novo Nordisk Investigational Site, Brighton, BN2 5BE, United Kingdom|Novo Nordisk Investigational Site, Coventry, CV6 2FL, United Kingdom|Novo Nordisk Investigational Site, Edinburgh, EH16 4SA, United Kingdom|Novo Nordisk Investigational Site, Glasgow, G42 9TY, United Kingdom|Novo Nordisk Investigational Site, Northampton, NN1 5BD, United Kingdom|Novo Nordisk Investigational Site, Plymouth, PL8 8DQ, United Kingdom|Novo Nordisk Investigational Site, York, YO3 7HE, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00600626

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress